Strategic Wealth Partners, Ltd. Natera, Inc. Transaction History

Strategic Wealth Partners, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 19, 2022	SELL	$30.32 - $91.33 $317,996 - $957,869	-10,488 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$86.26 - $119.0 $415,859 - $573,699	4,821 Added 85.07%	10,488 $979,000
Q3 2021 Nov 12, 2021	BUY	$100.17 - $126.36 $154,762 - $195,226	1,545 Added 37.48%	5,667 $632,000
Q2 2021 Aug 25, 2021	BUY	$86.05 - $119.72 $32,612 - $45,373	379 Added 10.13%	4,122 $468,000
Q1 2021 May 24, 2021	BUY	$91.47 - $124.36 $342,372 - $465,479	3,743 New	3,743 $380,000

547

118M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Strategic Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Strategic Wealth Partners, Ltd. with notifications on news.